Cytori Therapeutics, Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cytori Therapeutics, Inc.

An SI Board Since August 2005

Posts	SubjectMarks	Bans	Symbol
251	17	0	CYTX

Emcee: SnowShredder	Type: Moderated

Introduction Market Data Compact

From their website...

cytoritx.com

"Cytori Therapeutics is discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose, also known as fat tissue. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem cells, Cytori is developing its proprietary Celution™ system to isolate and concentrate a patient's own stem cells in approximately a one-hour period of time. This system will dramatically improve the speed in which personalized, cell-based therapies can be delivered to patients.

Cytori's MacroPore Biosurgery division develops and manufactures innovative bioresorbable, surgical implants. MacroPore Biosurgery manufactures the HYDROSORB™ family of FDA-cleared bioresorbable spine and orthopedic implants, which are distributed worldwide exclusively through Medtronic, Inc. Additionally, MacroPore Biosurgery is developing Thin Film bioresorbable implants exclusively for Senko Medical Trading Co., which has distribution rights exclusively in Japan."

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
251	Multiple miRNA Markers Associated with Angiogenesis and Tissue Injury Repair Exp	SnowShredder	-	10/7/2012
250	Cytori Awarded Contract Valued up to $106 Million by Biomedical Advanced Researc	SnowShredder	-	9/28/2012
249	Restore 2 publication... Prospective trial of Adipose-Derived Regenerative Cell	SnowShredder	-	3/27/2012
248	Stem cells from fat win favor with heart researcher For future reference... r	SnowShredder	-	3/25/2012
247	FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850 SAN DIEGO, CA--(Marketw	SnowShredder	-	3/16/2012
246	Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American C	SnowShredder	-	1/24/2012
245	Terrell Owens uses fat stem cells to speed up recovery of his knee (~1:30 into t	SnowShredder	-	10/6/2011
244	CYTORI ENTERS STRATEGIC EQUITY DEAL WITH ASTELLAS PHARMA; TO SELL $10 MILLION IN	SnowShredder	-	12/7/2010
243	Chronic Radiation Injury treatment publication, free to download the pdf... sag	SnowShredder	-	12/3/2010
242	Adipose-Derived Regenerative Cells Improve Cardiac Functional Capacity at 18 Mon	tnsaf	-	11/17/2010
241	Cytori Announces Exercise in Full of Overallotment Option and Closing of Public	tnsaf	-	10/13/2010
240	Cytori Therapeutics Prices Public Offering of Common Stock SAN DIEGO, Oct 08, 2	tnsaf	-	10/9/2010
239	Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Fu	tnsaf	-	10/7/2010
238	Cytori's stem-cell device gets European approval for new uses Best of Luck,	SnowShredder	-	8/6/2010
237	Just one letter off in its ticker, but this was ALMOST good news for Cytori...	Ian@SI	-	7/22/2010
236	<PRECISE> Cytori Reports Stem & Regenerative Cells from Body Fat Produ	SnowShredder	-	5/7/2010
235	<APOLLO> Cytori Reports Stem & Regenerative Cells from Body Fat Improv	SnowShredder	-	5/7/2010
234	Stock option benefit narrows Cytori 1Q loss Cytori posts smaller 1st-qtr loss du	tnsaf	-	5/6/2010
233	Cytori Stem Cell Cardiac Data Preview By Adam Feuerstein 05/05/10 - 11:48 AM EDT	tnsaf	-	5/6/2010
232	"FDA is requiring them to do a trial for cosmetic application." I tak	tuck	-	3/13/2010
231	Hi Tuck, FDA is requiring them to do a trial for cosmetic application. It is a	SnowShredder	-	3/13/2010
230	Cytori firesaling on greater than expected expenses. I don't follow the com	tuck	-	3/12/2010
229	Duckers et al (ACC poster title)... "First-in-Man Experience of Adipose-De	SnowShredder	-	3/12/2010
228	FDA decision due soon, Apollo trial abstract at ACC in March...should be interes	SnowShredder	-	2/18/2010
227	Periurethral injection of autologous adipose-derived stem cells for the treatmen	SnowShredder	-	2/18/2010

Go to reply# or date (mm/dd/yy):